Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Bertrand

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
VH gene replacement in thymocytesR Golub, D Martin, F E Bertrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
The J chain gene is transcribed during B and T lymphopoiesis in humansF E Bertrand, L G Billips, G L Gartland, et al.
Annals of the New York Academy of Sciences|September 29, 1995
Developmental regulation of the human antibody repertoireH W Schroeder, F Mortari, S Shiokawa, et al.
Blood|July 15, 1997
Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrowF E Bertrand, L G Billips, P D Burrows, et al.
Leukemia|January 23, 2004
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesisL S Steelman, S C Pohnert, J G Shelton, et al.
Immunological Reviews|August 10, 2000
Microenvironmental influences on human B-cell developmentF E Bertrand, C E Eckfeldt, J R Fink, et al.
The Journal of Experimental Medicine|October 1, 1995
Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitorsL G Billips, C A Nuñez, F E Bertrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birthS Shiokawa, F Mortari, J O Lima, et al.
Leukemia|April 28, 2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cellsF E Bertrand, L S Steelman, W H Chappell, et al.
Leukemia|October 17, 2003
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002R A Larson, G Q Daley, C A Schiffer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001
VH gene replacement in thymocytesR Golub, D Martin, F E Bertrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
The J chain gene is transcribed during B and T lymphopoiesis in humansF E Bertrand, L G Billips, G L Gartland, et al.
Annals of the New York Academy of Sciences|September 29, 1995
Developmental regulation of the human antibody repertoireH W Schroeder, F Mortari, S Shiokawa, et al.
Blood|July 15, 1997
Ig D(H) gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrowF E Bertrand, L G Billips, P D Burrows, et al.
Leukemia|January 23, 2004
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesisL S Steelman, S C Pohnert, J G Shelton, et al.
Immunological Reviews|August 10, 2000
Microenvironmental influences on human B-cell developmentF E Bertrand, C E Eckfeldt, J R Fink, et al.
The Journal of Experimental Medicine|October 1, 1995
Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitorsL G Billips, C A Nuñez, F E Bertrand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 1999
IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birthS Shiokawa, F Mortari, J O Lima, et al.
Leukemia|April 28, 2006
Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cellsF E Bertrand, L S Steelman, W H Chappell, et al.
Leukemia|October 17, 2003
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002R A Larson, G Q Daley, C A Schiffer, et al.
Pageof 3